Sevoflurane is the most widely used anaesthetic administered by inhalation. Exposure to sevoflurane in neonatal mice can induce learning deficits and abnormal social behaviours. MicroRNA (miR)-27a-3p, a short, non-coding RNA that functions as a tumour suppressor, is up-regulated after inhalation of anaesthetic, and peroxisome proliferator-activated receptor c (PPAR-c) is one of its target genes. The objective of this study was to investigate how the miR-27a-3p-PPAR-c interaction affects sevoflurane-induced neurotoxicity. A luciferase reporter assay was employed to identify the interaction between miR-27a-3p and PPAR-c. Primary hippocampal neuron cultures prepared from embryonic day 0 C57BL/6 mice were treated with miR-27a-3p inhibitor or a PPAR-c agonist to determine the effect of miR-27a-3p and PPAR-c on sevoflurane-induced cellular damage. Cellular damage was assessed by a flow cytometry assay to detect apoptotic cells, immunofluorescence to detect reactive oxygen species, western blotting to detect NADPH oxidase 1/4 and ELISA to measure inflammatory cytokine levels. In vivo experiments were performed using a sevoflurane-induced anaesthetic mouse model to analyse the effects of miR-27a-3p on neurotoxicity by measuring the number of apoptotic neurons using the Terminal-deoxynucleoitidyl Transferase Mediated Nick End Labeling (TUNEL) method and learning and memory function by employing the Morris water maze test. Our results revealed that PPAR-c expression was down-regulated by miR27a-3p following sevoflurane treatment in hippocampal neurons. Down-regulation of miR-27a-3p expression decreased sevoflurane-induced hippocampal neuron apoptosis by decreasing inflammation and oxidative stress-related protein expression through the up-regulation of PPAR-c. In vivo tests further confirmed that inhibition of miR-27a-3p expression attenuated sevoflurane-induced neuronal apoptosis and learning and memory impairment. Our findings suggest that downregulation of miR-27a-3p expression ameliorated sevofluraneinduced neurotoxicity and learning and memory impairment through the PPAR-c signalling pathway. MicroRNA-27a-3p may, therefore, be a potential therapeutic target for preventing or treating sevoflurane-induced neurotoxicity.
In recent years, concern has been raised over the safety of childhood anaesthesia (Servick 2014; Loepke and Hansen 2015) and the risks to the foetus of anaesthesia during pregnancy (Zheng et al. 2013) . There is evidence from animal studies that various general anaesthetics may be neurotoxic to the developing brain. For example, Young et al. (2005) reported that relatively mild exposure to the anaesthetic drugs ketamine, midazolam or a combination of these drugs triggered apoptotic neurodegeneration in the developing mouse brain. It is thought that the developing brain is susceptible to these agents during the brain growth spurt period, which in rodents occurs primarily during the first 2 weeks after birth but in humans extends from about midgestation to several years of age (Dobbing and Sands 1979) .
Sevoflurane is commonly used as an inhaled anaesthetic during surgery and is widely used in paediatric anaesthesia. Studies in children have shown that multiple exposures to general anaesthesia at an early age may be associated with the development of learning and memory disabilities (Wilder et al. 2009; Flick et al. 2011) . Similarly, a number of studies in rodents reported that early-life long-duration (6-9 h) exposure to high concentrations (3-4%) of sevoflurane could cause neuroinflammation, neuronal apoptosis and the inhibition of neurogenesis in the brain tissue, resulting in long-term cognitive impairment affecting learning and memory (Zou et al. 2009; Lu et al. 2010 Lu et al. , 2016 Wang et al. 2012 Wang et al. , 2013 Lei et al. 2013; Nie et al. 2013; Shen et al. 2013; Zhang et al. 2013a,b; Zhou et al. 2013) . However, as reported by Zou et al. (2009) , the degree and potentially the mechanisms of neurotoxicity associated with inhaled anaesthetics (ketamine in their case) during critical developmental periods are dose and exposure time dependent. Lu et al. (2016) found that a brief (3 h) early exposure to 2% sevoflurane (which was clinically relevant) could lead to cognitive dysfunction but this did not involve a mechanism of neuroapoptosis, and they suggested that other sevoflurane-induced mechanisms leading to long-term cognitive deficiency may exist.
MicroRNAs (miRNAs) are small, endogenous, highly conserved, non-coding RNA molecules (19-25 bp in length) that post-transcriptionally regulate the expression of target genes by binding to the 3 0 -untranslated region of the mRNA, resulting in translation inhibition or mRNA degradation (Filipowicz et al. 2008) . Human cells harbour numerous miRNAs that, by specifically regulating target gene expression, control a range of cellular processes including proliferation, differentiation and tumourigenesis. As with many other miRNAs, miR-27a, located on chromosome 19 (Mertens-Talcott et al. 2007) , is aberrantly expressed in various human cancers exerting either an oncogenic or tumour suppressive function (Calin and Croce 2006; Nelson and Weiss 2008) . An association has also been reported between the aberrant expression of miRNAs and exposure to anaesthetics such as sevoflurane Tanaka et al. 2012; Goto et al. 2014) . For example, Yu et al. (2016) reported that sevoflurane-induced learning and memory impairments in rats might be mediated via the miR27b-LIM domain kinase 1 (LIMK1) signalling pathway. They demonstrated that up-regulation of miR-27b decreased the expression of downstream LIMK1, which plays a potential role in cognitive dysfunction in rats.
The transcription factor peroxisome proliferator-activated receptor c (PPAR-c) plays a central role in modulating cellular metabolism, differentiation, apoptosis and invasion, as well as inflammation and oxidative stress (Guan and Breyer 2001; Li et al. 2013; Tan et al. 2013) . A link has been reported between exposure to sevoflurane and down-regulation of PPAR-c expression. In a recent study, Zhao et al. (2015) showed that exposure of young mice to sevoflurane-induced neuronal apoptosis and neurogenesis inhibition potentially impairs learning and memory. They also showed that sevoflurane down-regulated PPAR-c expression, with the PPAR-c agonist, rosiglitazone, attenuating sevoflurane-induced neuronal apoptosis, promoting neurogenesis and inhibiting learning and memory impairment. These findings indicated that sevoflurane may mediate its neurotoxicity and cognitive impairment through the PPAR-c signalling pathway. The gene encoding PPAR-c is one of the target genes of miR-27a-3p. In this study, we investigated whether the miRNA-27a-3p-PPAR-c interaction contributes towards the neurotoxicity and cognitive impairments that have been linked to sevoflurane exposure. Neuronal apoptosis was evaluated by flow cytometry and TUNEL staining, and cognitive functions were assessed in mice by the Morris water maze test.
Materials and methods

Anaesthesia exposure and ethics statement
The animal experiments were approved by the Animal Care Committee of the Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine (Shanghai, China). Pregnant C57BL/ 6 mice were purchased from the Animal Centre of Shanghai Jiao Tong University School of Medicine (RRID:IMSR_JAX:013186). All mice were separately housed under standard laboratory conditions (12 : 12 light/dark cycle, 22°C and 60% humidity) with free access to tap water and food. Seven-day-old male mice were used in the experiments. The littermate mice were arbitrarily divided into two groups including sevoflurane treatment groups and an air only control group. Animals in the anaesthesia groups received 2.2% sevoflurane (~1.0 minimum alveolar concentration) for 2 h/day on three consecutive days. The concentrations of anaesthetic, oxygen and carbon dioxide in the chamber were continuously monitored (GE Datex 5 Ohmeda, Tewksbury, MA, USA). A warming blanket was used to maintain the rectal temperature between 37 and 38°C. All experimental mice were returned to their cages after recovery. No mortality occurred during administration of anaesthesia or in the 2 weeks following administration of anaesthesia. After three consecutive doses of anaesthetic, some of the mice in each group were killed with pentobarbital, and their brains were extracted and preserved in liquid nitrogen for protein and mRNA analysis. The remaining mice from each treatment group were tested for learning and memory function once they reached a certain age. To determine the effect of miR-27a-3p on injury of the hippocampus, the miR27a-3p interference lentivirus vector was injected into the bilateral hippocampus immediately after exposure to the first dose of anaesthesia. To investigate the effect of PPAR-c on injury of the hippocampus, the PPAR-c agonist, rosiglitazone (RSG) as previously reported , was prepared fresh with sterile saline to a concentration of 0.1 mg/mL, and then 3 mg/kg was administrated intraperitoneally 2 h prior to each sevoflurane anaesthesia.
Stereotaxic injection of mice with lentiviral vectors
The miR-27a-3p interference (simiR-27a-3p) lentivirus vector and negative control (NC) lentivirus vector were purchased from GeneChem Co., Ltd. (Shanghai, China). Vector GV209 (H1-MCS-CMV-EGFP) was employed, and a titre of 1 9 10 9 TU/mL of lenti-simiR-27a-3p was used for these experiments. The mice received a lentiviral vector injection immediately after anaesthesia on the first day of exposure. After the administration of anaesthesia, the mice were placed onto a stereotaxic frame, and 5 lL of lentisimiR-27a-3p or NC vector was injected into the bilateral hippocampus (4.3 mm posterior to bregma, 3.5 mm lateral from midline, 3.3 mm ventral to bregma) using a 10 lL steppermotorized microsyringe (Pigeon, Shanghai, China) at a rate of 1 lL/min. The needle was maintained in place for another 5 min after injection.
Morris water maze test
The cognitive performance of the mice was assessed using the Morris water maze (MWM) test. The MWM test is the most widely used technique in behavioural neuroscience for studying neural mechanisms of spatial learning and memory. The test was administered by an operator blinded to the treatment groups. The MWM consisted of a round steel pool (122 cm in diameter and 60 cm in height), which was filled with water to a level of 1 cm above the top of a platform (10 cm in diameter and 30 cm in depth). The pool was surrounded by a blue curtain with cues and was located in an isolated quiet room (20°C, 60% humidity). The water was maintained at 21°C and opacified with titanium dioxide. The MWM test began at postnatal day 40, or day 34 from the beginning of sevoflurane exposure, and was continued for 5 days. The first 4 days (P40-P43) comprised a place navigation test (reference memory test), which consisted of 16 training trials: four trials per day for 4 days with an inter-trial interval of 30-40 min. At the beginning of each trial, the animals were placed into water facing the wall, from different start positions (north, south, east or west) and allowed 60 s to find the hidden platform and 15 s to stay on it. If the animal failed to locate the platform within 60 s, it was gently guided to the platform and allowed to stay on it for 15 s. A video tracking system was used to record the swimming activities of the animals. The escape latency (i.e. the time from dipping into the water to staying on the platform) was recorded. On the fifth day (day 44), a spatial probe test was performed in which the platform was removed from the pool. The mouse was placed in the opposite quadrant and allowed to swim freely for 120 s. The number of platform crossings was recorded. Data were analysed using motion detection software designed for the MWM test (Shanghai Mobile Datum Information Technology Co, Ltd., Shanghai, China).
Cell culture and treatment Primary hippocampal neuron cultures were obtained using a previously published method (Liu et al. 2012) . Briefly, the hippocampus was isolated from postnatal day 0 C57BL/6 mice pups, cut into small pieces and then digested with 0.125% trypsin for 15 min at 37°C. After trituration and centrifugation, the cells were seeded onto poly-D-lysine (10 mmol/L)-coated 10-mm dishes at a density of 1 9 10 6 cells/mL and were maintained in neurobasal medium (Gibco, Carlsbad, CA, USA) supplemented with 2% B27 (Gibco) and 0.25% Glumax (Gibco). After 3 days, 2.5 lg/mL cytosine arabinoside (Sigma-Aldrich, St. Louis, MO, USA) was added to the culture medium for 24 h to inhibit the proliferation of glial cells. Fifty per cent of the medium was replaced every third day. The cells were maintained at 37°C with 5% CO 2 for 14 days prior to experiments.
To mimic the conditions of anaesthesia by sevoflurane in vitro, the low glucose Dulbecco's modified Eagle's medium used for hippocampal neuron cultures was replaced with glucose-free neurobasal medium supplemented with 1% B27 and 2.78 mmol/L glucose according to a previous study (Wang et al. 2016) . The cells were maintained at 37°C with 5% CO 2 under induction with 4% sevoflurane for 6 h with/without treatment with RSG (5 lM). Then, hippocampal neurons were then cultured under normal conditions for 24 h. The isolated neurons were identified by immunofluorescence using a bIII tubulin (Sigma-Aldrich) stain.
To investigate the effect of miR-27a-3p on cellular survival, an inhibitor of miR-27a-3p (AM10750; Thermo Fisher Scientific, Rockford, IL, USA) was transfected into cells by calcium phosphate precipitation according to a previous study (Yu et al. 2016 ) before treatment with sevoflurane. The RNA was isolated from the treated cells for miRNA and mRNA analysis.
TUNEL staining
Hippocampal tissues were plated onto coverslips in 24-well culture plates, and an apoptosis detection kit (Roche, Indianapolis, IN, USA) was used to detect DNA fragmentation of individual cells according to the manufacturer's instructions. The nuclei were stained with DAPI (2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride), and TUNEL staining was assessed. Nuclei that were double-labelled with DAPI and TUNEL were considered positive.
In vitro transfection of miRNA inhibitors Cells were plated in 96-well plates (5 9 10 5 cells/well) in antibiotic-free medium for 24 h prior to transfection. The cells were transfected with miR-27a-3p inhibitor or a corresponding negative scramble RNA at a final concentration of 50 nM using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocols. After 48 h of transfection, the cells were harvested for further analysis.
Cell viability assay
Cell viability was evaluated using a Cell Counting Kit-8 assay (Beyotime Biotechnology, Jiangsu, China). Cells were cultured in 96-well plates at a density of 1 9 10 4 per well. To each well, 100 lL of culture medium was added mixed with 10 lL of Cell Counting Kit-8 reagent and incubated for 2 h in 95% (vol/vol) O 2 and 5% (vol/vol) CO 2 . The absorbance was measured using a microplate reader at 450 nm. Cell viability was calculated by the following formula: (OD treatment/OD control) 9 100%. Each experiment was repeated at least three times.
Cell apoptosis assay
Flow cytometry was used to determine the percentage of apoptotic cells. Apoptotic cells were differentiated from viable or necrotic cells by the combined application of annexin V (AV)-FITC (RRID: AB_2242811) and propidium iodide (PI) (RRID: AB_10831669).
Cells were washed twice and adjusted to a concentration of 1 9 10 6 cells/mL with cold D-Hanks buffer. Then, AV-FITC (10 lL) and PI (10 lL) were added to 100 lL of cell suspension and incubated for 15 min at 24-26°C in the dark. Finally, 400 lL of binding buffer was added to each sample without washing and analysed using flow cytometry. Each experiment was performed at least in triplicate.
Immunofluorescence Cells or hippocampal tissues were incubated with bIII tubulin (RRID: AB_2288015) or GFAP (RRID: IMSR_HAR:6678) antibodies overnight, then conjugated secondary antibody for 1 h at 24-26°C in the dark. After several washes with phosphate-buffered saline, the slides were incubated with DAPI for 3 min and then mounted in glycerol. Fluorescence was assessed under a fluorescence microscope. For luciferase assays, cells were cultured in 24-well plates and co-transfected with 50 ng of the corresponding vectors containing firefly luciferase together with 25 ng of miR-27a mimics or control. Transfection was performed using Lipofectamine 2000 reagent (Invitrogen). At 48 h post-transfection, relative luciferase activity was calculated by normalizing the firefly luminescence to the Renilla luminescence using a Dual-Luciferase Reporter Assay (Promega, Madison, WI, USA) according to the manufacturer's instructions.
Luciferase reporter assay
Western blot analysis
Cells or hippocampal tissues were harvested and lysed in Triton X-100 lysis buffer containing 25 mM Tris-HCl (pH 7.5), 137 mM NaCl, 2.7 mM KCl, 1% Triton X-100 and protease inhibitor cocktail (Sigma, St Louis, MO, USA) for 30 min at 4°C. Then, purified proteins were detected by sodium dodecyl sulphatepolyacrylamide gel electrophoresis using a 12% separating gel and a 5% stacking gel followed by staining with Coomassie blue to determine the purity of the enzyme preparations. Then, western blotting analysis was performed as follows: the proteins were transferred from sodium dodecyl sulphate-polyacrylamide gel electrophoresis gels onto nitrocellulose membranes by electroblotting and were then blocked in Tris-buffered saline-T buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl and 0.2% Tween-20) for 1 h at 24-26°C with 5% non-fat milk. Next, the membrane was probed with antibody I (His-tagged polyclonal antibody) followed by antibody II (alkaline phosphatase conjugated anti-rabbit IgG) and incubated with the Lumi-PhosTM WB (Pierce, Rockford, IL, USA) chemiluminescent substrate for 5 min. Protein expression levels were measured by the densitometry of the bands on the films using ImageJ 1.48u4 software (National Institutes of Health, Maryland, USA), and the data were normalized against the corresponding loading control (GAPDH).
RNA extraction and qRT-PCR Total RNA was extracted from tissues or cells using Trizol reagent (Invitrogen) according to the manufacturer's instructions. Total RNA was eluted with RNase-free water and stored at À80°C. RNA concentrations were determined by Epoch spectrophotometry. Quantification of mature miR-27a-3p and endogenous control miRNA U6 was performed using TaqMan assays 000409 and 001006 with the supplied assay-specific RT primers (Applied Biosystems, Foster City, CA, USA). The data were analysed using the 2 ÀDDCt method.
Statistical analysis
Continuous variables are presented as the mean AE standard deviation (SD). Statistical analysis was performed using the one-way ANOVA with post hoc tests for comparisons between two groups using GraphPad Prism 5.0 software (GraphPad Software, Inc., La Jolla, CA, USA). p ≤ 0.05 indicates a statistically significant difference. A sample size calculation was not performed in this study.
Results
Sevoflurane toxicity in primary cultured hippocampal neurons The isolated cells were determined to be hippocampal neuronal cells because they expressed the immunofluorescent neuron-specific protein bIII tubulin, but they did not display glial-specific protein GFAP expression ( Fig. 1a and b) indicating that the presence of glial cells was negligible.
To assess the toxicity of sevoflurane against hippocampal neuronal cells, cells were treated with varying doses of sevoflurane (0%, 1%, 2% and 4%) for 6 h. After incubation, cell viability was determined using the CCK8 cell counting kit, which measured cell proliferation and indirectly reflected the viability of neurons exposed to various concentrations of sevoflurane. As shown in Fig. 1(c) and (d), the viability of neuronal cells decreased with increasing sevoflurane concentration (p < 0.05 at 1% sevoflurane, p < 0.01 at 2% and 4% sevoflurane).
Role of miR-27a-3p in sevoflurane-induced hippocampal neuron injury To investigate the potential role of miR-27a-3p in sevoflurane-induced neuronal cell injury, as indicated by cellular apoptosis, hippocampal neurons were pretreated with miR27a-3p inhibitor before being exposed to 4% sevoflurane for 6 h. Flow cytometric analysis revealed that the significant increase in apoptosis in cells treated with 4% sevoflurane compared with untreated cells (p < 0.001) was attenuated by pretreatment with an miR-27a-3p inhibitor (p < 0.01 compared with the control or with 4% sevoflurane-treated cells) ( Fig. 2a and b) . This indicated that inhibition of miR-27a-3p activity reduced the harmful effects of sevoflurane in neuronal cells. The effect of sevoflurane on miR-27a-3p expression levels was confirmed by real-time PCR (Fig. 2c) .
The expression levels of miR-27a-3p were significantly increased by treatment of the cells with 4% sevoflurane (p < 0.001 compared with untreated cells), but decreased by pretreatment with an miR-27a-3p inhibitor (p < 0.001 compared with sevoflurane-treated cells) to close to control cell levels. Next, the effects of sevoflurane exposure on the generation of reactive oxygen species (ROS) by the neuronal cells were assessed, along with the role of miR-27a-3p, by immunofluorescence and Dihydroethidium (DHE) staining ( Fig. 2d and e) . The results indicated that exposure of neuronal cells to 4% sevoflurane caused a significant increase in ROS (p < 0.001 compared with untreated cells), and this effect was diminished by pretreatment with an miR27a-3p inhibitor (p < 0.001 compared with untreated and sevoflurane-treated cells). The expression of oxidative stress-related proteins NADPH oxidase 1/4 (NOX1/4) Fig. 2 Role of miR-27a-3p in sevoflurane-induced hippocampal neuron injury. Hippocampal neurons were preteated with miR-27a-3p inhibitor before exposure to 4% sevoflurane for 6 h. (a) Cell apoptosis was analysed by flow cytometry after double-labelling with annexin V-FITC and PI. (b) The percentage of cells undergoing apoptotic cell death in each group of cells subjected to different treatments. The data (n = 3, each experimental group has at least three repeats) are presented as the mean AE SD. ***p < 0.001 versus the control. ## p < 0.01 versus the 4% sevoflurane-treated group. (c) The expression levels of miR-27a-3p were measured by real-time PCR. The data (n = 5, each experimental group has at least five repeats) are presented as the mean AE SD. ***p < 0.001 versus the control. (d and e) The immunofluorescence and average fluorescence intensity of DHE and DAPI in each group. DHE staining represents the expression of reactive oxygen species. The data (n = 10, each experimental group has at least 10 field repetition) are presented as the mean AE SD. ***p < 0.001 versus the control, ### p < 0.001 versus the 4% sevoflurane-treated group. (f-h) The expression of oxidative stress-related proteins NADPH oxidase 1/4 (NOX1/4) was measured by western blot analysis. GAPDH expression levels were detected as an endogenous control. The data (n = 5, each experimental group comprised at least five repeats) are presented as the mean AE SD. *p < 0.05, **p < 0.01, ***p < 0.001 versus the control and ### p < 0.001 versus the 4% sevoflurane-treated group. (i-k) The levels of secretion of inflammatory cytokines IL-6, IL-1b and tumour necrosis factor-a into the cell culture supernatants were measured by ELISA. The data (n = 5, each experimental group comprised at least five repeats) are presented as the mean AE SD, n = 5. **p < 0.01, ***p < 0.001 versus the control, #p < 0.05 and ### p < 0.001 versus the 4% sevoflurane-treated group. followed similar patterns. Western blot analysis revealed that NOX1/4 expression was significantly increased in response to sevoflurane treatment (p < 0.001 compared with untreated cells), but decreased on pretreatment with an miR27a-3p inhibitor (p < 0.001 compared with sevofluranetreated cells, p < 0.05/p < 0.01 compared with untreated cells) (Fig. 2f-h) . Finally, the inflammatory cytokine secretion levels of interleukin 6 (IL-6), IL-1b and tumour necrosis factor a (TNF-a) in the cell culture supernatants were measured by ELISA (Fig. 2i-k) . The expression of inflammatory cytokines was significantly up-regulated in response to sevoflurane treatment (p < 0.001, p < 0.01 and p < 0.001, respectively, compared with untreated cells), and this effect was attenuated by pretreatment with an miR-27a-3p inhibitor (p < 0.001, p < 0.05 and p < 0.001, respectively, compared with sevoflurane-treated cells; p < 0.01 for IL-6 compared with untreated cells).
Effect of PPAR-c on sevoflurane-induced, miR-27a-3p-mediated, hippocampal neuron injury
To investigate the effect of PPAR-c on injury of the hippocampus, the PPAR-c agonist, RSG, was employed. The significant increase in the proportion of apoptotic cells following exposure to 4% sevoflurane (p < 0.001 compared with control cells) was reduced by co-treatment with RSG (p < 0.001 compared with sevoflurane-treated cells, p < 0.01 compared with the control), as shown by flow cytometry after double-labelling with annexin V-FITC and PI ( Fig. 3a and b) . This indicated that inhibition of PPAR-c activity reduced the harmful effects of sevoflurane in neuronal cells. Real-time PCR confirmed that miR-27a-3p expression levels were unaffected by RSG treatment (Fig. 2c) , indicating that changes in miR-27a-3p expression were not responsible for the reduction in apoptosis seen in RSG-treated cells.
Next, immunofluorescence and DHE staining were performed to assess the effects of sevoflurane exposure and PPAR-c on the generation of ROS by neuronal cells (Fig. 3d  and e) . The increase in ROS observed in response to sevoflurane exposure (p < 0.001 compared with the control) was reduced by co-treatment with RSG (p < 0.001 compared with untreated and sevoflurane-treated cells), indicating the role of PPAR-c in sevoflurane-mediated toxicity. Western blot analysis confirmed these findings indicating that the NOX1/4 proteins were attenuated in expression following treatment with RSG (p < 0.001/p < 0.01 compared with sevoflurane-treated cells, p < 0.01 compared with untreated cells) (Fig. 3f-h) . Finally, the analysis of cytokine expression in the culture supernatants of sevoflurane-treated cells by ELISA indicated that co-treatment with RSG removed the sevoflurane-induced increase in IL-1b and TNF-a expression back to control cell levels ( Fig. 3i-k) . IL-6 was the only cytokine assessed that showed a significant increase in expression on co-treatment with sevoflurane and RSG (p < 0.01) compared with control cells, but levels were still decreased compared with sevoflurane treatment alone (p < 0.01).
PPAR-c is a potential target of miR-27a-3p
To confirm whether PPAR-c is a target of miR-27a-3p, the 3 0 -UTR of PPAR-c mRNA was analysed using publicly available algorithms, and a complementary sequence was identified (Fig. 4a) . A mutated version of the PPAR-c 3 0 -UTR was generated in which nine complementary nucleotides in the binding site were altered (Fig. 4b) , and this mutated construct was fused to the luciferase coding region (PYr-PPAR-c 3 0 -UTR) and co-transfected into HK-2 cells along with miR-27a-3p mimics (Fig. 4c) . Determination of the relative luciferase activity revealed that when the wild-type PPAR-c 3 0 -UTR was co-transfected with miR-27a-3p mimics, PPAR-c expression was significantly decreased (p < 0.001) compared with co-transfection with control miRNA. However, this effect was not observed when the mutant PPAR-c 3 0 -UTR construct was used for co-transfection indicating the specific targeting and suppression of the 3 0 -UTR of PPAR-c by miR-27a-3p.
RT-PCR was employed to check the expression levels of miR-27a-3p in cells transfected with miR-27a-3p mimics (Fig. 4d) , and a significant increase was evident (p < 0.001) compared with untransfected cells and cells transfected with control miRNAs. Then, western blot analysis was employed to check the protein expression levels of PPAR-c in the neuronal cells after transfection with miR-27a-3p mimics ( Fig. 4e and f) , and a significant decrease was evident (p < 0.001) compared with untransfected cells and cells transfected with control miRNAs. The average fluorescence intensity of DHE in each group. n = 10. The data (n = 10, each experimental group comprised at least 10 field repetitions) are presented as the mean AE SD. ***p < 0.001 versus the control, ### p < 0.001 versus the 4% sevoflurane-treated group. (f-h) The expression of oxidative stress-related proteins NADPH oxidase 1/ 4 (NOX1/4) was measured by western blot analysis. GAPDH expression levels were detected as an endogenous control. The data (n = 5, each experimental group comprised at least five repeats) are presented as the mean AE SD. **p < 0.01, ***p < 0.001 versus the control, ## p < 0.01 and ### p < 0.001 versus the 4% sevofluranetreated group. (i-k) The levels of secretion of inflammatory cytokines IL-6, IL-1b and tumour necrosis factor-a in the cell culture supernatants were measured by ELISA. The data (n = 5, each experimental group comprised at least five repeats) are presented as the mean AE SD. **p < 0.01, ***p < 0.001 versus the control and ## p < 0.01 versus the 4% sevoflurane-treated group.
Inhibition of miR-27a-3p decreased sevoflurane-induced neuronal apoptosis and neurogenesis through up-regulation of PPAR-c expression in vivo A time course of experiments was designed to carefully analyse the effects of sevoflurane exposure postnatally in mice, as shown in the schematic in Fig. 5 . This involved a range of techniques to analyse both the molecular and cellular changes in neuronal tissue along with phenotypic or behavioural changes in mice following exposure to sevoflurane. The postnatal mice were exposed to 2.2% sevoflurane for 2 h per day on days 7, 8 and 9. Then, molecular analyses including RT-PCR, western blot analysis, IHC and ELISA were performed on hippocampus tissues sampled from postnatal mice on days 10 and 45 to investigate the effects of the interaction between miR-27a-3p and its target PPAR-c in vivo.
Firstly, the expression of miR-27a-3p was analysed by RT-PCR of the hippocampus tissue of mice injected with either miR-27a-3p interference (simiR-27a-3p) lentivirus vector or negative control (NC) lentivirus vector immediately after exposure to the first dose of anaesthesia (Fig. 6a) . The increase in miR-27a-3p expression levels in neuronal cells in HK-2 cells with miR-27a-3p mimics to confirm that PPAR-c is the target of miR-27a-3p. The PYr-PPAR-c 3 0 -UTR and miR-27a-3p mimic constructs were co-transfected into HK-2 cells with a control vector, and the relative luciferase activity was determined 48 h after transfection. The data (n = 5, each experimental group comprised at least five repeats) are presented as the mean AE SD. ***p < 0.001 versus the control. (d) RT-PCR was used to analyse the expression of miR-27a-3p in the co-transfected cells. The data (n = 5, each experimental group comprised at least five repeats) are presented as the mean AE SD of three separate experiments. ***p < 0.001 versus the control. (e and f) Western blot analysis of the effect of expression of PPAR-c in hippocampal neurons after transfection with miR-27a-3p mimics. GAPDH expression levels were detected as an endogenous control. The data (n = 5, each experimental group comprised at least five repeats) are presented as the mean AE SD. ***p < 0.001 versus the control.
response to sevoflurane exposure in wild-type mice at postnatal (P) days 10 (p < 0.001) and 45 (p < 0.05) compared with control cells was not observed in the cells of mice injected with simiR-27a-3p. Control cells and cells from P10 and P45 from mice injected with simiR-27a-3p all showed significantly reduced miR-27a-3p expression levels compared with wild-type mice (p < 0.001). This confirmed the induced expression of miR-27a-3p over the time course post anaesthesia and the effectiveness of the simiR-27a-3p lentivirus vector at silencing miR-27a-3p expression. Next, the protein expression levels of PPAR-c in the hippocampus tissues of mice exposed to sevoflurane over the postnatal time course were analysed by western blot analysis ( Fig. 6b  and c) . Silencing of miR-27a-3p using the simiR-27a-3p lentivirus vector resulted in up-regulation of PPAR-c in control cells (p < 0.001 compared with wild-type cells) and in sevoflurane-treated P10 and P45 cells, indicating that miR27a-3p may suppress the expression of PPAR-c in wild-type cells. To assess the effects of miR-27a-3p silencing on apoptosis and the generation of ROS in neuronal cells, immunofluorescence was performed ( Fig. 6d-f) . In control cells, transfection with the simiR-27a-3p lentivirus vector reduced the relative apoptotic rate (p < 0.001 compared with wild-type) and the rate of ROS generation (p < 0.01 compared with wild-type). Exposure to sevoflurane caused a significant increase in both apoptosis and the generation of ROS in wild-type cells at P10 and P45 (p < 0.001 vs. control cells), but this was reversed by inhibition of miR-27a-3p (p < 0.001 compared with wild-type). The same pattern was observed on western blot analysis of the oxidative stressrelated proteins NOX1/4 (Fig. 6g) , with down-regulation of these proteins in response to miR-27a-3p inhibition in sevoflurane-exposed cells. Finally, the analysis of inflammatory cytokine secretion levels (IL-6, IL-1b and TNF-a) by ELISA also revealed the same pattern, with down-regulation of these proteins in response to miR-27a-3p inhibition (p < 0.001 compared with wild-type cells) following sevoflurane exposure (Fig. 6h-j) . Taken together, these findings suggest that miR-27a-3p targets and suppresses the expression of PPAR-c in neuronal cells in vivo, allowing for increased levels of apoptosis and neuroinflammation, in particular following sevoflurane exposure.
Inhibition of miR-27a-3p decreased sevoflurane-induced cognitive impairments To investigate the cognitive ability of mice following exposure to sevoflurane, the MWM test was performed, a widely used technique for assessing spatial learning and memory (Fig. 7a) . Mice in the sevoflurane treatment groups exhibited significantly longer periods of escape latency than those in the control group. Furthermore, down-regulation of the expression of miR-27a-3p, by injection of the mice with the simiR-27a-3p lentivirus vector, significantly decreased the percentage of time spent by the mouse in the target quadrant. During the spatial probe test, the number of platform crossings decreased in the sevoflurane treatment groups but increased after down-regulation of miR-27a-3p expression compared with the control group (Fig. 7b ). These findings indicated that inhibition of miR-27a-3p decreased sevoflurane-induced cognitive impairments.
Discussion
There is a growing concern that exposure to anaesthetic drugs can cause widespread apoptotic neurodegeneration in the developing brain (Servick 2014; Loepke and Hansen 2015) . It is thought that a substantial reduction in neuronal cell numbers during early brain development could lead to persistent cognitive abnormalities in adulthood (Satomoto et al. 2009; Chung et al. 2015) . Previous studies have investigated the mechanism of sevoflurane-induced neuroapoptosis. Microarray analysis by Chen et al. (2016) revealed the aberrant expression of a range of apoptosisrelated long non-coding RNAs in response to sevoflurane exposure (Chen et al. 2016) . In particular, they proposed that up-regulation of the long non-coding RNA ENSMUST00000136025 induced over-expression of BIM, which ultimately promoted mitochondria-mediated apoptosis. Whereas Liu et al. (2017) demonstrated the involvement of the PERK-eIF2a-ATF4-CHOP axis of the endoplasmic reticulum stress signalling pathway in response to sevoflurane exposure, and Yu et al. (2016) provided evidence that sevoflurane-induced learning and memory impairments in rats were mediated via the miR-27b-LIMK1 signalling pathway.
In the current study, we focused on the aberrant expression of miR-27a-3p following anaesthesia. Our findings confirmed that exposure to the anaesthetic sevoflurane decreases cell viability among hippocampal neuronal cells. Using an miR-27a-3p inhibitor, we demonstrated the role of miR-27a-3p in sevoflurane-mediated neurotoxicity. Silencing of miR27a-3p effectively reduced the percentage of apoptotic cells, All experiments were performed on the hippocampus tissues of mice exposed to 2.2% sevoflurane (Sevo) and treated with/without the simiR-27a-3p lentivirus vector at postnatal (P) days 10 and 45. (a) The expression of miR-27a-3p in hippocampus tissues was measured by RT-PCR. The data (n = 5, each experimental group comprised at least five repeats) are presented as the mean AE SD. ***p < 0.001 versus WT. (g) The expression of oxidative stress-related proteins NADPH oxidase 1/4 (NOX1/4) was measured by western blot analysis. n = 5. GAPDH expression levels were detected as an endogenous control. (h-j) The inflammatory cytokine secretion levels of IL-6, IL-1b and tumour necrosis factor-a in the hippocampus were measured by ELISA. The data (n = 5, each experimental group comprised at least five repeats) are presented as means AE SD. **p < 0.01, ***p < 0.001 versus WT. the generation of ROS, NOX1/4 expression and the expression of inflammatory cytokines (IL-6, IL-1 and TNF) in sevoflurane-treated cells. These same effects were observed when the expression of PPAR-c, a target of miR-27a-3p, was promoted using the agonist RSG in sevoflurane-treated cells. We proceeded to demonstrate the specific inhibition of PPAR-c by miR-27a-3p using a luciferase reporter assay. Our in vivo experiments in postnatal mice injected with an miR-27a-3p interference lentivirus vector further confirmed that it is the suppression of PPAR-c mediated by miR-27a-3p that contributes to sevoflurane-induced neurotoxicity and cognitive impairments. Thereby implying that therapeutic strategies focusing on relieving this suppression by miR-27a-3p silencing may be effective at reducing the detrimental effects of anaesthesia.
Although our findings provide evidence that the miR27a-3p-PPAR-c interaction plays a role in mediating the neurotoxicity associated with sevoflurane exposure in the developing brain, it is likely that other factors are involved, and these mechanisms are yet to be fully elucidated. For example, Fujimoto et al. (2015) reported changes in a number of nerve development-related microRNAs, including rno-miRNA-632, mmu-miR-211 and mmu-miR-872, in the hippocampus of neonatal rats in response to sevoflurane exposure, leading to subsequent behavioural disorders. Lu et al. (2017) found that miR-665 had a neuroprotective effect by suppressing sevoflurane anaesthesia-induced cognitive dysfunction in rats through the PI3K/Akt signalling pathway by targeting insulin-like growth factor 2.
Our work has several limitations. Firstly, it is worth acknowledging that data collected from animal models do not always completely correspond to the pathophysiology of humans, and it is important to use experimental parameters that most closely reflect clinical medicine. However, the close agreement between our in vitro and in vivo data strengthens the experimental evidence. Secondly, our study focused exclusively on the miR-27a-3p-PPAR-c interaction, and the role of other factors in the mechanistic response to sevoflurane exposure will be the subject of future studies. Thirdly, our results indicated statistically significant changes despite the small group sizes, but future studies should assess large cohorts. Fourthly, it is possible that microglia may be responsible for some of the cytokines and other toxicityinducing factors produced. Staining would be required to exclude this possibility and confirm the neuron-specific effects. Finally, we did not demonstrate unequivocally that the effects of the miR inhibitor were limited to neurons, and staining for PPAR-c with GFAP or Iba1 would be needed to address this.
In summary, our findings provide insight into the mechanisms that mediate the neurotoxicity of sevoflurane and may prompt new therapeutic approaches to reducing the damaging effects of anaesthesia on the immature brains of paediatric patients. (b) Platform crossings were decreased in the sevoflurane treatment groups but increased after down-regulation of the expression of miR27a-3p compared with the control group. The data (n = 5, each group comprised five mice) are presented as the mean AE SD. *p < 0.05, **p < 0.01 versus WT control. ## p < 0.01 versus sevoflurane control.
